Literature DB >> 17901889

Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated cardiomyopathy.

P Alter1, H Rupp, M B Rominger, A Vollrath, F Czerny, K J Klose, B Maisch.   

Abstract

Ventricular loading conditions are crucial determinants of cardiac function and prognosis in heart failure. B-type natriuretic peptide (BNP) is mainly stored in the ventricular myocardium and is released in response to an increased ventricular filling pressure. We examined, therefore, the hypothesis that BNP serum concentrations are related to ventricular wall stress. Cardiac magnetic resonance imaging (MRI) was used to assess left ventricular (LV) mass and cardiac function of 29 patients with dilated cardiomyopathy and 5 controls. Left ventricular wall stress was calculated by using a thick-walled sphere model, and BNP was assessed by immunoassay. LV mass (r = 0.73, p < 0.001) and both LV end-diastolic (r = 0.54, p = 0.001) and end-systolic wall stress (r = 0.66, p < 0.001) were positively correlated with end-diastolic volume. LV end-systolic wall stress was negatively related to LV ejection fraction (EF), whereas end-diastolic wall stress was not related to LVEF. BNP concentration correlated positively with LV end-diastolic wall stress (r = 0.50, p = 0.002). Analysis of variance revealed LV end-diastolic wall stress as the only independent hemodynamic parameter influencing BNP (p < 0.001). The present approach using a thick-walled sphere model permits determination of mechanical wall stress in a clinical routine setting using standard cardiac MRI protocols. A correlation of BNP concentration with calculated LV stress was observed in vivo. Measurement of BNP seems to be sufficient to assess cardiac loading conditions. Other relations of BNP with various hemodynamic parameters (e.g., EF) appear to be secondary. Since an increased wall stress is associated with cardiac dilatation, early diagnosis and treatment could potentially prevent worsening of the outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901889     DOI: 10.1139/y07-076

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  15 in total

Review 1.  Protein NMR in biomedical research.

Authors:  W Jahnke; H Widmer
Journal:  Cell Mol Life Sci       Date:  2004-02-26       Impact factor: 9.261

2.  Intrapericardial procedures for cardiac regeneration by stem cells: need for minimal invasive access (AttachLifter) to the normal pericardial cavity.

Authors:  H Rupp; T P Rupp; P Alter; N Jung; S Pankuweit; B Maisch
Journal:  Herz       Date:  2010-10       Impact factor: 1.443

3.  The cause of B-type natriuretic peptide elevation and the dose-dependent effect of angiotensin-converting enzyme inhibitor on patients late after tetralogy of Fallot repair.

Authors:  Takuo Furukawa; Tomoaki Murakami; Michihiko Ueno; Atsuhito Takeda; Satoshi Yakuwa; Hirokuni Yamazawa
Journal:  Pediatr Cardiol       Date:  2011-09-30       Impact factor: 1.655

Review 4.  MR, CT, and PET imaging in pericardial disease.

Authors:  Peter Alter; Jens H Figiel; Thomas P Rupp; Georg F Bachmann; Bernhard Maisch; Marga B Rominger
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

5.  Diabetic cardiomyopathy--fact or fiction?

Authors:  B Maisch; P Alter; S Pankuweit
Journal:  Herz       Date:  2011-03       Impact factor: 1.443

6.  Effects of candesartan cilexetil "add-on" treatment in congestive heart failure outpatients in daily practice.

Authors:  Veselin Mitrovic; Karl-Friedrich Appel; Nicolaos Proskynitopoulos; Seyfettin Dereli; Christian Wilhelm Hamm
Journal:  Clin Res Cardiol       Date:  2009-03-18       Impact factor: 5.460

7.  A new methodological approach to assess cardiac work by pressure-volume and stress-length relations in patients with aortic valve stenosis and dilated cardiomyopathy.

Authors:  P Alter; H Rupp; M B Rominger; K J Klose; B Maisch
Journal:  Pflugers Arch       Date:  2007-08-25       Impact factor: 3.657

8.  Natriuretic peptides in chronic kidney disease.

Authors:  Rajat Tagore; Lieng H Ling; Hong Yang; Hla-Yee Daw; Yiong-Huak Chan; Sunil K Sethi
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-16       Impact factor: 8.237

9.  B-type natriuretic peptide and wall stress in dilated human heart.

Authors:  P Alter; H Rupp; M B Rominger; A Vollrath; F Czerny; J H Figiel; P Adams; F Stoll; K J Klose; B Maisch
Journal:  Mol Cell Biochem       Date:  2008-05-07       Impact factor: 3.396

10.  Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study.

Authors:  Federico Guerra; Ernesto Ammendola; Matteo Ziacchi; Vittorio Aspromonte; Pier Luigi Pellegrino; Giuseppe Del Giorno; Gabriele Dell'Era; Lorenzo Pimpini; Francesco Santoro; Roberto Floris; Giulia Stronati; Gerardo Nigro; Pasquale Paolisso; Alessandro Guido; Giampiero Maglia; Natale Daniele Brunetti; Angelo Carbone; Miriam Gravellone; Roberto Antonicelli; Michele Cannone; Michele Accogli; Antonio Dello Russo; Pietro Palmisano
Journal:  Eur J Clin Pharmacol       Date:  2021-07-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.